Providing confidential valuation guidance to Cannabis Innovation Center, a medical cannabis group at the frontier of multiple cannabis-based therapies.
Tel Aviv, Israel — 20 August 2021
Flow Partners acted as a financial advisor to Cannabis Innovation Center, a leading medical cannabis group operating a portfolio of brands with a focus on cannabinoid-based drug development.
Providing confidential valuation guidance to Cannabis Innovation Center, a medical cannabis group at the frontier of multiple cannabis-based therapies.
Tel Aviv, Israel — 20 August 2021
Flow Partners acted as a financial advisor to Cannabis Innovation Center, a leading medical cannabis group operating a portfolio of brands with a focus on cannabinoid-based drug development.
Overview
Management of CIC required an actionable valuation service in order to accurately position the business in the upcoming capital raising discussions.
We have provided an independent valuation opinion that included deep dive on medical cannabis space, development pipeline analysis, risk-adjusted NPV (rNPV), comparable environment analysis, operational benchmarking, green/red flag analysis and more.
This transaction continues Flow's successful track record of advising in the digital health sector, having also advised and valued companies like Cannadorf (medical cannabis), Code Pharma, BiomX (biotechnology) or AVE & YOU (personalized skincare).
About Cannabis Innovation Center
Cannabis Innovation Center is a biotechnology group specializing in pharmaceutical medical cannabis. The group's portfolio includes brands like Stero, CannaLean, CannaMore, Cannadu and BioSeed.
About Flow Partners
Flow Partners is a modern advisory firm providing independent corporate finance advice to companies and investors that shape the global digital ecosystem. Flow was founded in 2020 and operates globally with presence in London, Berlin, Warsaw and Miami.
For more information, please visit www.flowpartners.io
Enquiries
For all enquiries please contact the team at [email protected]